{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T07:02:34Z","timestamp":1795071754934,"version":"4.10.2"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T00:00:00Z","timestamp":1694131200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/ http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,3]]},"abstract":"<jats:p>Neuroendocrine carcinomas (NECs) of the cervix are rare, aggressive malignancies that are challenging to diagnose and treat. They are high-grade lesions that often share features with poorly differentiated adenocarcinoma and squamous cell carcinoma. NECs are classified into large-cell or small-cell subtypes but can often have a mixed appearance or occur concurrently with a squamous or adenocarcinoma. Diagnosis is dependent on tissue sampling, histomorphology, and immunohistochemistry. Eight cases of NEC were retrieved from the Department of Pathology at our institution from 2008 to 2022. Tumor slides were reviewed and evaluated by 2 independent pathologists. Seven of 8 patients tested positive for neuroendocrine markers, including CD56, synaptophysin, and chromogranin. We discuss the diagnostic challenges, review the histopathology, and describe the treatment courses and clinical outcomes. This case series reveals that traditional markers, such as p16, p63, and p40, may be focally positive in NEC and should not be considered a confirmation of squamous cell carcinoma. Patient outcomes can be affected by delays in diagnosis, misdiagnosis, and inadequate treatment when NEC is not considered in the initial differential diagnosis.<\/jats:p>","DOI":"10.1097\/pgp.0000000000000983","type":"journal-article","created":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T18:03:28Z","timestamp":1699034608000},"page":"149-157","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["Diagnostic Challenges and Long-term Outcomes of Neuroendocrine Carcinoma of the Cervix: A Case Series"],"prefix":"10.1097","volume":"43","author":[{"given":"Kelly","family":"Lamiman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyeesha B.","family":"Wilhelm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Eyzaguirre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwyn","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,9,8]]},"reference":[{"key":"R1-20250802","first-page":"586","article-title":"Evaluation of histologic, morphometric, and immunohistochemical criteria in the differential diagnosis of small cell carcinomas of the cervix with particular reference to human papillomavirus types 16 and 18","volume":"4","author":"Ambros","year":"1991","journal-title":"Mod Pathol"},{"key":"R2-20250802","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/00000478-199101000-00003","article-title":"Small-cell neuroendocrine carcinoma of the cervix. A human papillomavirus type 18-associated cancer","volume":"15","author":"Stoler","year":"1991","journal-title":"Am J Surg Pathol"},{"key":"R3-20250802","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.ygyno.2016.02.008","article-title":"Natural history and outcome of neuroendocrine carcinoma of the cervix","volume":"141","author":"Margolis","year":"2016","journal-title":"Gynecol Oncol"},{"key":"R4-20250802","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1586\/14737140.2015.1047767","article-title":"Challenges in the diagnosis and management of cervical neuroendocrine carcinoma","volume":"15","author":"Burzawa","year":"2015","journal-title":"Expert Rev Anticancer Ther"},{"key":"R5-20250802","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.ygyno.2017.12.001","article-title":"A systematic review and meta-analysis on the attribution of human papillomavirus (HPV) in neuroendocrine cancers of the cervix","volume":"148","author":"Castle","year":"2018","journal-title":"Gynecol Oncol"},{"key":"R6-20250802","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.pvr.2018.03.005","article-title":"Contribution of Human papillomavirus in neuroendocrine tumors from a series of 10,575 invasive cervical cancer cases","volume":"5","author":"Alejo","year":"2018","journal-title":"Papillomavirus Res"},{"key":"R7-20250802","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1136\/ijgc-2019-000504","article-title":"Updates and management algorithm for neuroendocrine tumors of the uterine cervix","volume":"29","author":"Salvo","year":"2019","journal-title":"Int J Gynecologic Cancer"},{"key":"R8-20250802","doi-asserted-by":"crossref","first-page":"3468","DOI":"10.1007\/s00261-018-1667-0","article-title":"Imaging and staging of neuroendocrine cervical cancer","volume":"43","author":"Elsherif","year":"2018","journal-title":"Abdominal Radioly"},{"key":"R10-20250802","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1186\/s12885-018-4447-x","article-title":"Neuroendocrine carcinoma of the cervix: a systematic review of the literature","volume":"18","author":"Tempfer","year":"2018","journal-title":"BMC Cancer"},{"key":"R11-20250802","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/(SICI)1097-0142(19981025)84:5<281::AID-CNCR3>3.0.CO;2-W","article-title":"Small cell carcinoma of the uterine cervix","volume":"84","author":"Zhou","year":"1998","journal-title":"Cancer"},{"key":"R12-20250802","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1007\/s00330-016-4327-1","article-title":"MR imaging features and staging of neuroendocrine carcinomas of the uterine cervix with pathological correlations","volume":"26","author":"Duan","year":"2016","journal-title":"Eur Radiol"},{"key":"R13-20250802","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.ijrobp.2016.11.015","article-title":"Diffusion-weighted magnetic resonance imaging as a predictor of outcome in cervical cancer after chemoradiation","volume":"97","author":"Ho","year":"2017","journal-title":"Int J Radiation Oncol"},{"key":"R14-20250802","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1136\/ijgc-2020-002213","article-title":"Role of radical hysterectomy in patients with early-stage high-grade neuroendocrine cervical carcinoma: a NeCTuR study","volume":"31","author":"Salvo","year":"2021","journal-title":"Int J Gynecologic Cancer"},{"key":"R15-20250802","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1097\/AOG.0b013e318173570b","article-title":"Incidence, Mortality, and Prognostic Factors of Small Cell Carcinoma of the Cervix","volume":"111","author":"Chen","year":"2008","journal-title":"Obstetr Gynecol"},{"key":"R16-20250802","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ygyno.2017.10.027","article-title":"Prognostic factors and optimal therapy for stages I\u2013II neuroendocrine carcinomas of the uterine cervix: a multi-center retrospective study","volume":"148","author":"Ishikawa","year":"2018","journal-title":"Gynecol Oncol"},{"key":"R17-20250802","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1200\/JCO.2003.01.501","article-title":"Small-cell carcinoma of the cervix: fourteen years of experience at a single institution using a combined-modality regimen of involved-field irradiation and platinum-based combination chemotherapy","volume":"21","author":"Hoskins","year":"2003","journal-title":"J Clin Oncol"},{"key":"R18-20250802","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/cncr.11086","article-title":"Prognostic factors in neuroendocrine small cell cervical carcinoma","volume":"97","author":"Chan","year":"2003","journal-title":"Cancer"},{"key":"R19-20250802","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ygyno.2011.04.011","article-title":"Neuroendocrine tumors of the gynecologic tract: A Society of Gynecologic Oncology (SGO) clinical document","volume":"122","author":"Gardner","year":"2011","journal-title":"Gynecol Oncol"},{"key":"R20-20250802","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ygyno.2016.10.040","article-title":"Combination therapy with topotecan, paclitaxel, and bevacizumab improves progression-free survival in recurrent small-cell neuroendocrine carcinoma of the cervix","volume":"144","author":"Frumovitz","year":"2017","journal-title":"Gynecol Oncol"},{"key":"R21-20250802","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0090-8258(02)00150-6","article-title":"Endocrine tumors of the uterine cervix: incidence, demographics, and survival with comparison to squamous cell carcinoma","volume":"88","author":"McCusker","year":"2003","journal-title":"Gynecol Oncol"},{"key":"R22-20250802","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1136\/jclinpath-2011-200274","article-title":"A clinicopathological aspect of primary small-cell carcinoma of the uterine cervix: a single-center study of 25 cases","volume":"64","author":"Li","year":"2011","journal-title":"J Clin Pathol"},{"key":"R23-20250802","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/PAS.0000000000000633","article-title":"Neuroendocrine carcinoma of the endometrium","volume":"40","author":"Pocrnich","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R24-20250802","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1038\/s41379-018-0110-y","article-title":"A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal","volume":"31","author":"Rindi","year":"2018","journal-title":"Mod Pathol"}],"container-title":["International Journal of Gynecological Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PGP.0000000000000983","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T19:00:41Z","timestamp":1754161241000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PGP.0000000000000983"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,8]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/pgp.0000000000000983","relation":{},"ISSN":["0277-1691"],"issn-type":[{"value":"0277-1691","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9,8]]}}}